158 related articles for article (PubMed ID: 34465597)
1. CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.
Schroeder BA; LaFranzo NA; LaFleur BJ; Gittelman RM; Vignali M; Zhang S; Flanagan KC; Rytlewski J; Riolobos L; Schulte BC; Kim TS; Chen E; Smythe KS; Wagner MJ; Mantilla JG; Campbell JS; Pierce RH; Jones RL; Cranmer LD; Pollack SM
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34465597
[TBL] [Abstract][Full Text] [Related]
2. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
3. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification.
Yamashita K; Kohashi K; Yamada Y; Ishii T; Nishida Y; Urakawa H; Ito I; Takahashi M; Inoue T; Ito M; Ohara Y; Oda Y; Toyokuni S
Histopathology; 2018 Apr; 72(5):729-738. PubMed ID: 29076540
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
6. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
7. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract][Full Text] [Related]
8. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
Roland CL; Nassif Haddad EF; Keung EZ; Wang WL; Lazar AJ; Lin H; Chelvanambi M; Parra ER; Wani K; Guadagnolo BA; Bishop AJ; Burton EM; Hunt KK; Torres KE; Feig BW; Scally CP; Lewis VO; Bird JE; Ratan R; Araujo D; Zarzour MA; Patel S; Benjamin R; Conley AP; Livingston JA; Ravi V; Tawbi HA; Lin PP; Moon BS; Satcher RL; Mujtaba B; Witt RG; Traweek RS; Cope B; Lazcano R; Wu CC; Zhou X; Mohammad MM; Chu RA; Zhang J; Damania A; Sahasrabhojane P; Tate T; Callahan K; Nguyen S; Ingram D; Morey R; Crosby S; Mathew G; Duncan S; Lima CF; Blay JY; Fridman WH; Shaw K; Wistuba I; Futreal A; Ajami N; Wargo JA; Somaiah N
Nat Cancer; 2024 Apr; 5(4):625-641. PubMed ID: 38351182
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma.
Choi B; Lee JS; Kim SJ; Hong D; Park JB; Lee KY
Cancer Lett; 2020 May; 478():56-69. PubMed ID: 32145342
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive immune characterization and T-cell receptor repertoire heterogeneity of retroperitoneal liposarcoma.
Yan L; Wang Z; Cui C; Guan X; Dong B; Zhao M; Wu J; Tian X; Hao C
Cancer Sci; 2019 Oct; 110(10):3038-3048. PubMed ID: 31385405
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the MDM2/HMGA2 ratio and histological tumor grade in dedifferentiated liposarcoma.
Yamashita K; Kohashi K; Yamada Y; Akatsuka S; Ikuta K; Nishida Y; Toyokuni S; Oda Y
Genes Chromosomes Cancer; 2021 Jan; 60(1):26-37. PubMed ID: 33111425
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
14. Influence of age and subtype in outcome of operable liposarcoma.
Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
[TBL] [Abstract][Full Text] [Related]
15. Oncogene mutation profiling reveals poor prognosis associated with FGFR1/3 mutation in liposarcoma.
Li C; Shen Y; Ren Y; Liu W; Li M; Liang W; Liu C; Li F
Hum Pathol; 2016 Sep; 55():143-50. PubMed ID: 27237367
[TBL] [Abstract][Full Text] [Related]
16. Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma.
Gootee J; Aurit S; Curtin C; Silberstein P
J Cancer Res Clin Oncol; 2019 Jan; 145(1):181-192. PubMed ID: 30361927
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis.
Ghadimi MP; Al-Zaid T; Madewell J; Peng T; Colombo C; Hoffman A; Creighton CJ; Zhang Y; Zhang A; Lazar AJ; Pollock RE; Lev D
Ann Surg Oncol; 2011 Dec; 18(13):3762-70. PubMed ID: 21614627
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of dedifferentiated liposarcoma in the extremities: A retrospective case series of 7 patients.
Kito M; Yoshimura Y; Isobe K; Aoki K; Suzuki S; Tanaka A; Okamoto M; Sano K; Kato H
J Orthop Sci; 2016 Sep; 21(5):673-7. PubMed ID: 27317086
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of the tumor immune microenvironment in synovial sarcoma.
Oike N; Kawashima H; Ogose A; Hotta T; Hatano H; Ariizumi T; Sasaki T; Yamagishi T; Umezu H; Endo N
Cancer Sci; 2018 Oct; 109(10):3043-3054. PubMed ID: 30133055
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
